BackFoghorn Therapeutics Overview

Foghorn Therapeutics Selling, General & Admin

Selling, General & Admin expenses for FHTX.

Quarterly SG&A Expenses

$6.58M
↓ 9.09% YoY

As of Mar 31, 2026

Annual SG&A Expenses (TTM)

$26.89M
↓ 3.57% YoY

Trailing 12 months ending Mar 31, 2026

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin